Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4058 results

Sort By:

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Study ID: NCT06649812
Start Date: 2026-03-21
End Date: 2027-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Ibrutinib

Lenalidomide

Magnetic Resonance Imaging

Obinutuzumab

Positron Emission Tomography

Prednisone

Venetoclax

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Study ID: NCT06871410
Start Date: 2025-08-01
End Date: 2028-04-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

26

Intervention / Treatment

Autologous Anti-CD83 CAR T-cells

Biospecimen Collection

Chest Radiography

Computed Tomography

Cyclophosphamide

Echocardiography

Fludarabine Phosphate

Hydroxyurea

Leukapheresis

Lumbar Puncture

Positron Emission Tomography

Administration questionnaire

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive

Study ID: NCT06636214
Start Date: 2026-08-31
End Date: 2029-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1200

Intervention / Treatment

Boring

Sponsor

University of Kansas Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Novel Delivery Method of Transgender Voice Therapy Using a Mobile Application

Study ID: NCT05815810
Start Date: 2025-11
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Attuned: A mobile application

In-Person Voice Modification Therapy

Sponsor

Weill Medical College of Cornell University

Source: clinicaltrials.gov

Share:
Add to list

Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes

Study ID: NCT06820281
Start Date: 2025-12-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Tirzepatide 2.5mg weekly

Placebo injection (normal saline)

Sponsor

Garvan Institute of Medical Research

Source: clinicaltrials.gov

Share:
Add to list

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Study ID: NCT07029581
Start Date: 2025-08
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

180

Intervention / Treatment

ACP-204

Placebo

Sponsor

ACADIA Pharmaceuticals Inc.

Source: clinicaltrials.gov

Share:
Add to list

Geriatrics in the Intensive Care Unit

Study ID: NCT07001410
Start Date: 2025-08
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Age group

Sponsor

Villavicencio Departmental Hospital

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).

Study ID: NCT06967610
Start Date: 2025-10-30
End Date: 2033-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Pester

Venetoclax

Obinutuzumab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support

Study ID: NCT06840210
Start Date: 2025-08-01
End Date: 2030-08-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200000

Intervention / Treatment
Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

TRacheal Cuff PRessure Evaluation Study

Study ID: NCT06848010
Start Date: 2025-08-01
End Date: 2027-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

54

Intervention / Treatment

Automated endotracheal cuff controller

Sponsor

Hospital Polyclinic

Source: clinicaltrials.gov

Share:
Add to list